Ad hoc announcement: MeVis Medical Solutions completing stock buy-back program

MeVis Medical Solutions AG / stock buy-back

Bremen, June 17, 2008. Bremen-based MeVis Medical Solutions AG [ISIN DE000A0LBFE4], a specialist in disease-oriented software products for image-based medicine, today completed its stock buy-back program following the achievement of the five percent target.

Under a resolution passed at the annual general meeting on September 28, 2007, the Company is authorized to buy back up to ten percent of its own current share capital in accordance with Section 71 (1) No. 8 of the German Stock Corporations Act. As MeVis Medical Solutions already held 37,800 treasury shares at the commencement of its buy-back program, the Management Board decided on March 4, 2008 to initially buy back a further 53,200 of the Company’s shares by August 30, 2008 via the stock exchange. Under this stock buy-back program, the Company has acquired 53,200 of its own shares as of today’s date, equivalent to a total of € 1,502,589. All the stock was bought via the Xetra electronic trading platform and on the floor of the Frankfurt stock exchange via the Company's designated sponsor M.M. Warburg.

As a result, MeVis Medical Solutions AG’s treasury stock comprises a total of 91,000 shares, equivalent to five percent of its current share capital.

By buying back its own stock, the Company wants to gain additional strategic scope for acqui-sitions, the purchase of intellectual property, investments and similar transactions aimed at implementing its growth strategy. However, there are no specific plans for the utilization of the treasury stock at this stage. In view of the recent recovery in the price of MeVis stock, the Company’s Management Board has now decided against buying back any further shares for now.

Detailed information on the progress of the stock buy-back program to date in accordance with Art. 4 (3) and (4) of Commission Regulation (EC) No 2273/2003 of December 22, 2003 as regards exemptions for buy-back programs and stabilization of financial instruments in connection with Article 20 (1) of Council Directive 93/22/EEC of May 10, 1993 on investment services in the securities field is available at the Company’s website at